ah 13205 has been researched along with dinoprostone in 9 studies
| Studies (ah 13205) | Trials (ah 13205) | Recent Studies (post-2010) (ah 13205) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 16 | 0 | 1 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | ah 13205 (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, M; Kiriyama, M; Kobayashi, T; Narumiya, S; Sugimoto, Y; Ushikubi, F | 1 |
| Breyer, MD; Breyer, RM; Stillman, BA | 1 |
| Coleman, RA; McGrath, JC; Smith, GC | 1 |
| Lydford, SJ; McKechnie, K | 1 |
| al-Rashed, S; Hellewell, PG; Rossi, AG; Teixeira, MM | 1 |
| Barnes, PJ; Giembycz, MA; Meja, KK | 1 |
| Hu, DN; McCormick, SA; Woodward, DF | 1 |
| Krauss, AH; Lütjen-Drecoll, E; Richter, M; Woodward, DF | 1 |
| Belvisi, MG; Birrell, MA; Buckley, J; Clarke, DL; Maher, SA; Nials, AT | 1 |
9 other study(ies) available for ah 13205 and dinoprostone
| Article | Year |
|---|---|
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Topics: Animals; CHO Cells; Cricetinae; Ligands; Mice; Prostaglandins; Receptors, Prostaglandin; Transfection | 1997 |
Importance of the extracellular domain for prostaglandin EP(2) receptor function.
Topics: Amino Acid Sequence; Animals; Binding Sites; Biological Transport; COS Cells; Cyclic AMP; Humans; Ligands; Molecular Sequence Data; Protein Conformation; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship | 1999 |
Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus.
Topics: Animals; Dinoprostone; Dose-Response Relationship, Drug; Ductus Arteriosus; Epoprostenol; Female; In Vitro Techniques; Pregnancy; Prostaglandins; Prostanoic Acids; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane | 1994 |
Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Dinoprostone; Heptanoic Acids; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E, Synthetic; Prostanoic Acids; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Thromboxane A2; Trachea | 1994 |
Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Topics: Alprostadil; Analysis of Variance; Animals; Anti-Ulcer Agents; Carbazoles; Cell Aggregation; Dinoprostone; Dose-Response Relationship, Drug; Eosinophils; Female; Guinea Pigs; Indoles; Misoprostol; Oxytocics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin D2; Prostaglandins E, Synthetic; Prostanoic Acids; Protein Kinase C; Pyrroles; Receptors, Prostaglandin; Structure-Activity Relationship | 1997 |
Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Dinoprostone; Drug Interactions; Epoprostenol; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Prostaglandin; Thromboxane A2; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1997 |
A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Cell Count; Cells, Cultured; Cyclic AMP; Dinoprostone; Epoprostenol; Fibroblast Growth Factor 2; Humans; Hydantoins; Iris; Melanins; Melanocytes; Prostaglandin Antagonists; Prostanoic Acids; Receptors, Prostaglandin | 2001 |
Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
Topics: Administration, Topical; Amides; Animals; Anterior Eye Segment; Antihypertensive Agents; Bimatoprost; Ciliary Body; Cloprostenol; Dinoprostone; Intraocular Pressure; Latanoprost; Lipids; Macaca fascicularis; Muscle, Smooth; Nerve Fibers; Ophthalmic Solutions; Peripheral Nervous System; Prostaglandins F, Synthetic; Prostanoic Acids; Trabecular Meshwork | 2003 |
EP4 receptor as a new target for bronchodilator therapy.
Topics: Alprostadil; Animals; Asthma; Bridged Bicyclo Compounds, Heterocyclic; Bronchodilator Agents; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; Humans; Hydrazines; Macaca fascicularis; Methyl Ethers; Mice; Mice, Inbred C57BL; Naphthalenes; Phenylbutyrates; Prostanoic Acids; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Regression Analysis; Species Specificity; Trachea; Xanthones | 2011 |